Special Section

Focus on Childhood and Adolescent Mental Health

The objective of the Focus on Childhood and Adolescent Mental Health section is to encourage scientific studies regarding the mental health of children and adolescents, promote excellent clinical care of children and adolescents with psychiatric disorders, and help keep the psychiatric community informed about the latest research developments. In addition to manuscripts covering studies of the phenomenology of childhood and adolescent psychiatric disorders and clinical trials of treatments for childhood and adolescent psychiatric disorders and associated symptoms, authors are encouraged to submit manuscripts regarding the use of genomic and brain imaging studies related to childhood and adolescent mental health. Disorders include pediatric mood, anxiety, and psychotic disorders as well as oppositional defiant and conduct disorders, attention-deficit/hyperactivity disorder, pervasive developmental disorders, tic disorders, intellectual disability, other developmental disorders, and any other disorder that may present during childhood or adolescence. Other topics include any biological, psychosocial, economic, or health services aspect of childhood and adolescent mental health. We also invite manuscripts related to the scientific understanding, differential diagnosis, early detection and monitoring, treatment, and prevention of psychiatric disorders in children and adolescents.

JCP
Obsessive-Compulsive Symptoms and Psychosis Risk
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ October 16, 2023

Among youth at clinical high risk for psychosis, obsessive-compulsive symptoms had a high prevalence (50%) and were associated with a more severe clinical and functional profile.
JCP
Omega-3 PUFA Supplements for ADHD
JCP
Rumination, Resilience, and Depression in Adolescents
JCP
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management
JCP
Low Ghrelin and Anxiety in ARFID
JCP
Endothelial Function in Youth With Bipolar Disorder
JCP
Pharmacotherapy After CBT in Anxious Youth
JCP
Psychotropic Use in Youth With MDD and ADHD
JCP
C-Reactive Protein, Attention, and Gray Matter in Offspring of Patients With Bipolar Disorder
JCP
Parental Mental Illness and Child Injury Risk
JCP
Cannabidiol for Treatment-Resistant Anxiety
JCP
Transdiagnostic PRS Prediction of Mood Disorders